HUTCHMED (China) Limited has signed agreements to sell its 45% equity stake in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for approximately USD$ 608 million in cash to GP Health Service Capital Co., Ltd and Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma). The divestment follows HUTCHMED’s strategic evaluation of options to monetize its non-core, non-consolidated joint venture … HUTCHMED China Secures USD$ 608 Million in Strategic 45% Shanghai Operations Divestment Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.